This brand name is authorized in Brazil, Cyprus, Italy, Japan, Malta, UK, United States.
The drug DECADRON contains one active pharmaceutical ingredient (API):
1
|
UNII
7S5I7G3JQL - DEXAMETHASONE
|
|
Dexamethasone is a synthetic glucocorticoid; it combines high anti-inflammatory effects with low mineralocorticoid activity. It has an approximately 7 times greater anti-inflammatory potency than prednisolone, another commonly prescribed corticosteroid. At high doses it reduces the immune response. |
|
Below package inserts are available for further reading:
| Document | Type | Information Source | |
|---|---|---|---|
| DECADRON Oral solution | MPI, US: SPL/Old | FDA, National Drug Code (US) |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| A01AC02 | Dexamethasone | A Alimentary tract and metabolism → A01 Stomatological preparations → A01A Stomatological preparations → A01AC Corticosteroids for local oral treatment |
| C05AA09 | Dexamethasone | C Cardiovascular system → C05 Vasoprotectives → C05A Agents for treatment of hemorrhoids and anal fissures for topical use → C05AA Corticosteroids |
| D07AB19 | Dexamethasone | D Dermatologicals → D07 Corticosteroids, dermatological preparations → D07A Corticosteroids, plain → D07AB Corticosteroids, moderately potent (group II) |
| D07XB05 | Dexamethasone | D Dermatologicals → D07 Corticosteroids, dermatological preparations → D07X Corticosteroids, other combinations → D07XB Corticosteroids, moderately potent, other combinations |
| D10AA03 | Dexamethasone | D Dermatologicals → D10 Anti-acne preparations → D10A Anti-acne preparations for topical use → D10AA Corticosteroids, combinations for treatment of acne |
| H02AB02 | Dexamethasone | H Systemic hormonal preparations, excl. Sex hormones and insulins → H02 Corticosteroids for systemic use → H02A CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN → H02AB Glucocorticoids |
| R01AD03 | Dexamethasone | R Respiratory system → R01 Nasal preparations → R01A Decongestants and other nasal preparations for topical use → R01AD Corticosteroids |
| S01BA01 | Dexamethasone | S Sensory organs → S01 Ophthalmologicals → S01B Antiinflammatory agents → S01BA Corticosteroids, plain |
| S01CB01 | Dexamethasone | S Sensory organs → S01 Ophthalmologicals → S01C Antiinflammatory agents and antiinfectives in combination → S01CB Corticosteroids/antiinfectives/mydriatics in combination |
| S02BA06 | Dexamethasone | S Sensory organs → S02 Otologicals → S02B Corticosteroids → S02BA Corticosteroids |
| S03BA01 | Dexamethasone | S Sensory organs → S03 Ophthalmological and otological preparations → S03B Corticosteroids → S03BA Corticosteroids |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| BR | Câmara de Regulação do Mercado de Medicamentos | 500510401114411, 500510402110411, 500510404113416, 500510406132418 |
| GB | Medicines & Healthcare Products Regulatory Agency | 390132, 390134 |
| IT | Agenzia del Farmaco | 014729141 |
| JP | 医薬品医療機器総合機構 | 2454002F1183, 2454002F3020, 2454002S1122, 2454405H1024, 2454405H3027, 2454405H5020 |
| MT | Medicines Authority | AA565/89301 |
| US | FDA, National Drug Code | 58463-014, 58463-015, 58463-016, 58463-017 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.